Clinical Trial Update: Post Market Registry for the Omnipod 5 System in Children and Adults With Type 1 Diabetes

View source ↗

Summary

Insulet's post-market registry study of the Omnipod 5 insulin delivery system for children and adults with Type 1 diabetes is currently recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Type 1 Diabetes Mellitus

Drugs mentioned

• Omnipod 5 insulin delivery system

Snippet

Sponsor: Insulet Corporation | Conditions: Type 1 Diabetes | Status: RECRUITING